# BIOTARGET DX LLC: Dual-Platform Plasma Assay for Early Lung Cancer Detection in African Americans

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | BIOTARGET DX LLC |
| Location | HANOVER, MD |
| Project | Dual-Platform Plasma Assay for Early Lung Cancer Detection in African Americans |
| Project number | 1R43MD021361-01 |
| Mechanism | R43 |
| Institute | National Institute on Minority Health and Health Disparities |
| Award | $295,924 |
| Awarded | 2026-08-28 |
| Project period | 2026-09-01 to 2027-08-31 |
| UEI | XTERX9QBKVV7 |

## Why this score
- Award of $295,924.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11329410). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.